Geron Corporation (GERN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Geron Corporation, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.97
−15.78% today
Market cap
$739M
Overall quality
48/100
Kronos AI 30-day
+14.1%
8 of 8 simulated paths end higher
Geron Corporation (GERN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $739M. It trades at $0.97, down 15.78% today. Its overall quality score is 48 out of 100, ranked against the whole US market. 3 analysts' average target of $4.33 implies +346.4% from today's price. Kronos AI's 30-day forecast is +14.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.33 |
| Low – high | $3.00 – $6.00 |
| Analysts | 3 |
| Upside to average | +346.4% |
Kronos AI 30-day forecast
| Expected close | $1.31 (+14.1%) |
| Likely range | +10.6% … +16.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 19 |
| Solvency | 47 |
| Growth | 79 |
| Overall | 48 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.